American Cancer Society Head and Neck Cancer Survivorship Care Guideline
2016/03/22 by Ezra E.W. Cohen, Ezra E. W. Cohen, Samuel J. LaMonte +13 · 27 citations
Medicine · #Head and Neck Cancer Studies #Cancer survivorship and care #Oral health in cancer treatment
paper · pdf · doi:10.3322/caac.21343
Abstract
Answer questions and earn CME/CNE The American Cancer Society Head and Neck Cancer Survivorship Care Guideline was developed to assist primary care clinicians and other health practitioners with the care of head and neck cancer survivors, including monitoring for recurrence, screening for second primary cancers, assessment and management of long-term and late effects, health promotion, and care coordination. A systematic review of the literature was conducted using PubMed through April 2015, and a multidisciplinary expert workgroup with expertise in primary care, dentistry, surgical oncology, medical oncology, radiation oncology, clinical psychology, speech-language pathology, physical medicine and rehabilitation, the patient perspective, and nursing was assembled. While the guideline is based on a systematic review of the current literature, most evidence is not sufficient to warrant a strong recommendation. Therefore, recommendations should be viewed as consensus-based management strategies for assisting patients with physical and psychosocial effects of head and neck cancer and its treatment. CA Cancer J Clin 2016;66:203-239. © 2016 American Cancer Society.
Citations
Cited by
- Trends, timing, and predictors of alcohol use disorder treatment among US adult cancer survivors
- Neighborhood-level disadvantage and lifestyle-based supportive care in head and neck cancer: insights from the Midwestern United States
- Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. [europepmc]
- Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. [europepmc]
- Long-Term and Latent Side Effects of Specific Cancer Types. [europepmc]
- Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma. [europepmc]
- Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop. [europepmc]
- Personalized Risk-Stratified Cancer Follow-Up Care: Its Potential for Healthier Survivors, Happier Clinicians, and Lower Costs. [europepmc]
- A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer. [europepmc]
- A methodological systematic review of meta-ethnography conduct to articulate the complex analytical phases. [europepmc]
- Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors. [europepmc]
- Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit. [europepmc]
- Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. [europepmc]
- NCCN Guidelines Insights: Survivorship, Version 2.2019. [europepmc]
- Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment. [europepmc]
- Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. [europepmc]
- Tipifarnib as a Precision Therapy for HRAS -Mutant Head and Neck Squamous Cell Carcinomas. [europepmc]
- ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer. [europepmc]
- A systematic review of rehabilitation and exercise recommendations in oncology guidelines. [europepmc]
- LncRNA SNHG3, a potential oncogene in human cancers. [europepmc]
- Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population. [europepmc]
- Outcomes of cancer survivorship education and training for primary care providers: a systematic review. [europepmc]
- Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. [europepmc]
- The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors. [europepmc]
- Incidence and Risk of Suicide Among Patients With Head and Neck Cancer in Rural, Urban, and Metropolitan Areas. [europepmc]
- The Overexpression of Fibronectin 1 Promotes Cancer Progression and Associated with M2 Macrophages Polarization in Head and Neck Squamous Cell Carcinoma Patients. [europepmc]
- Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach. [europepmc]
Related